3
Views
1
CrossRef citations to date
0
Altmetric
Research

Editorial Cardiovascular & Renal: Anti-atherosclerotic patents following the success of HMG-CoA reductase inhibitors

Pages 427-430 | Published online: 29 Feb 2008

References to Primary Literature

  • PEDERSON TR, KJEKSHUS J, BERG K et al.: Randomised trial of cholesterol-lowering in 4444 patients with coro-nary-heart-disease - the Scandinavian simvastatin sur-vival study (4S). Lancet (1994) 344:1383–1389.
  • SHEPHERD J,COBBE SM, FORD I et al.: Prevention of coronary heart diseases with pravastatin in men with hypercholesterolemia. New England J. Med. (1995) 333:1301–1307.
  • PYORALA K, DEBACKER G, GRAHAM I et al: Preventionof coronary heart disease in clinical-practice, recom-mendation of the task-force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis (1994) 110:121–161.
  • STEPHENS NG, PARSONS A, SCHOFIELD PM et al.: Ran-domised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet (1996) 347:781–786.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.